Chinese Journal of Tissue Engineering Research ›› 2020, Vol. 24 ›› Issue (26): 4106-4111.doi: 10.3969/j.issn.2095-4344.2665

Previous Articles     Next Articles

Guided bone regeneration combined with kidney-tonifying therapy for repairing femoral bone defect in rats

Xie Lei1, Zhang Yan1, Jiang Ziwei2, Shen Zhen1, Feng Junming1, Hao Chengyi1, Cai Yangting3    

  1. 1Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong Province, China; 2the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong Province, China; 3Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510405, Guangdong Province, China

  • Received:2019-10-22 Revised:2019-10-24 Accepted:2019-12-13 Online:2020-09-18 Published:2020-08-29
  • Contact: Cai Yangting, Master, Attending physician, Guangdong Provincial Hospital of Traditional Chinese Medicine,Guangzhou 510405, Guangdong Province, China
  • About author:Xie Lei, Master candidate, Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong Province, China
  • Supported by:

    the National Natural Science Foundation of China, No. 81774337; the Research Foundation of Traditional Chinese Medicine Bureau of Guangdong Province, No. 20181080; the Medical Science and Technology Research Foundation of Guangdong Province, No. B2018097

Abstract:

BACKGROUND: Guided bone regeneration technology, as a most widely used method for repairing bone defects, has been extensively used in the field of stomatology. However, there are few reports on the guided bone regeneration technology in long bone defects.

OBJECTIVE: To explore the effects of guided bone regeneration combined with kidney-tonifying therapy on the repair of femoral bone defects in rats, and investigate its osteogenic efficacy and underlying mechanism.

METHODS: Thirty-six Sprague-Dawley rats were randomly divided into six groups: blank group, guided bone regeneration group, high-, moderate-, and low-dose kidney-tonifying groups, and ossotide tablets group. The femur bone defect model of rats was established, and was treated by guided bone regeneration except for blank group. Bio-Gide collagen membrane combined with autologous bone was implanted by guided bone regeneration. The kidney-tonifying groups were given 0.216, 0.108 and 0.054 g/(kg•d) Qianggu capsule via gavage for 8 weeks. The ossotide tablets group was given 0.58 mg/(kg•d) ossotide tablets via gavage for 8 weeks. At 12 weeks after surgery, the osteogenesis was evaluated by X-ray examination, hematoxylin-eosin staining and Masson staining of bone tissue. The mRNA expression levels of alkaline phosphatase, Runx-2, vascular endothelial growth factor and bone morphogenetic protein-2 in bone tissues were detected by quantitative real-time RT-PCR.

RESULTS AND CONCLUSION: Results of X-ray examination and hematoxylin-eosin staining and Masson staining of bone tissue showed that the scores of Lane Sandhu and Huddleston in each group were significantly higher than those in the blank group (P < 0.001). The scores in the high- and moderate-dose kidney-tonifying groups were significantly higher than those in the guided bone regeneration group (P < 0.01). RT-PCR results showed that the mRNA expression levels of alkaline phosphatase, Runx-2, vascular endothelial growth factor and bone morphogenetic protein-2 in bone tissue in the high- and moderate-dose kidney-tonifying groups were significantly higher than those in the blank group (P < 0.01), and were superior to the guided bone regeneration group (P < 0.05). In summary, guided bone regeneration combined with kidney-tonifying can significantly promote the repair of femoral bone defects, reduce bone absorption and improve osteogenic efficacy in rats. The mechanism of promoting bone regeneration and angiogenesis may be by up-regulating the expression of related osteogenic factors and angiogenic factors in the environment where the membrane barrier creates a dominant growth of bone tissue.

Key words: femur, bone defects, guided bone regeneration technology, kidney-tonifying therapy, Bio-Gide collagen membrane, osteogenic efficiency

CLC Number: